Organovo Inc. (ONVO)
0.34
-0.01 (-3.95%)
At close: Jan 15, 2025, 3:59 PM
0.35
1.45%
After-hours Jan 15, 2025, 04:11 PM EST
undefined% (undefined)
| Bid | 0.34 |
| Market Cap | 5.30M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.04 |
| PE Ratio (ttm) | -0.33 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.35 |
| Volume | 83,339 |
| Avg. Volume (20D) | 205,627 |
| Open | 0.36 |
| Previous Close | 0.35 |
| Day's Range | 0.34 - 0.36 |
| 52-Week Range | 0.32 - 1.74 |
| Beta | undefined |
About ONVO
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive h...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 14, 2012
Employees 12
Stock Exchange NASDAQ
Ticker Symbol ONVO
Website https://www.organovo.com
Next Earnings Release
Organovo Inc. is scheduled to release its earnings on Jan 24, 2025,
during market hours.
Analysts project revenue of $50.00K, reflecting a n/a YoY growth and earnings per share of 0, making a -100.00% decrease YoY.
Analysts project revenue of $50.00K, reflecting a n/a YoY growth and earnings per share of 0, making a -100.00% decrease YoY.
2 months ago ·
Source
-0.39%
Organovo Holdings shares are trading higher after ...
Unlock content with
Pro Subscription
8 months ago ·
Source
+2.72%
Organovo Holdings shares are trading lower after the company announced the pricing of a $5.25 million public offering of 6,562,500 shares and common warrants.
